Cargando…

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians

IMPORTANCE: Transparency of industry payments to physicians could engender greater public trust in physicians but might also lead to greater mistrust of physicians and the medical profession, adversely affecting the patient-physician relationship. OBJECTIVE: To examine the association between nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanter, Genevieve P., Carpenter, Daniel, Lehmann, Lisa S., Mello, Michelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481437/
https://www.ncbi.nlm.nih.gov/pubmed/30977850
http://dx.doi.org/10.1001/jamanetworkopen.2019.1947
_version_ 1783413760804782080
author Kanter, Genevieve P.
Carpenter, Daniel
Lehmann, Lisa S.
Mello, Michelle M.
author_facet Kanter, Genevieve P.
Carpenter, Daniel
Lehmann, Lisa S.
Mello, Michelle M.
author_sort Kanter, Genevieve P.
collection PubMed
description IMPORTANCE: Transparency of industry payments to physicians could engender greater public trust in physicians but might also lead to greater mistrust of physicians and the medical profession, adversely affecting the patient-physician relationship. OBJECTIVE: To examine the association between nationwide public disclosure of industry payments and Americans’ trust in their physicians and trust in the medical profession. DESIGN, SETTING, AND PARTICIPANTS: Survey study using difference-in-difference analyses of a national longitudinal survey comparing changes in states where industry payments were newly disclosed by Open Payments with changes in states where payments information was already available because of state sunshine laws. The US population-based surveys were conducted in September 2014—shortly before the initial public disclosure of industry payments—and again in September 2016. Final analyses were conducted September through December 2018. Participants were adults 18 years and older (n = 1388). EXPOSURES: National public disclosure through Open Payments of payments made by pharmaceutical and medical device firms to physicians. MAIN OUTCOMES AND MEASURES: Wake Forest measure of trust in one’s own physician and Wake Forest measure of trust in the medical profession. RESULTS: Of the 3542 original survey respondents, 2180 (61.5%) completed the second survey 2 years later, and 1388 named the same most frequently seen physician in both surveys. The mean age of respondents at the time of the first survey was 53 years, and 749 (54.0%) were women. Race/ethnicity was white in 76.6% (1063 of 1388) and non-Hispanic black in 8.0% (111 of 1388). Public disclosure of payments was associated with lower trust in one’s own physician regardless of whether respondents knew their physicians had received payments (decrease in Wake Forest measure of trust in one’s own physician of 0.56 point; 95% CI, −0.79 to −0.32 point; P < .001). Open Payments was also associated with lower trust in the medical profession (decrease in Wake Forest measure of trust in the medical profession of 0.35 point; 95% CI, −0.58 to −0.12 point; P = .004). CONCLUSIONS AND RELEVANCE: Nationwide public disclosure of industry payments may be associated with decreased trust in physicians and in the medical profession. More judicious presentation of payments information may counteract unintended negative trust and spillover consequences of public disclosure.
format Online
Article
Text
id pubmed-6481437
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-64814372019-05-03 US Nationwide Disclosure of Industry Payments and Public Trust in Physicians Kanter, Genevieve P. Carpenter, Daniel Lehmann, Lisa S. Mello, Michelle M. JAMA Netw Open Original Investigation IMPORTANCE: Transparency of industry payments to physicians could engender greater public trust in physicians but might also lead to greater mistrust of physicians and the medical profession, adversely affecting the patient-physician relationship. OBJECTIVE: To examine the association between nationwide public disclosure of industry payments and Americans’ trust in their physicians and trust in the medical profession. DESIGN, SETTING, AND PARTICIPANTS: Survey study using difference-in-difference analyses of a national longitudinal survey comparing changes in states where industry payments were newly disclosed by Open Payments with changes in states where payments information was already available because of state sunshine laws. The US population-based surveys were conducted in September 2014—shortly before the initial public disclosure of industry payments—and again in September 2016. Final analyses were conducted September through December 2018. Participants were adults 18 years and older (n = 1388). EXPOSURES: National public disclosure through Open Payments of payments made by pharmaceutical and medical device firms to physicians. MAIN OUTCOMES AND MEASURES: Wake Forest measure of trust in one’s own physician and Wake Forest measure of trust in the medical profession. RESULTS: Of the 3542 original survey respondents, 2180 (61.5%) completed the second survey 2 years later, and 1388 named the same most frequently seen physician in both surveys. The mean age of respondents at the time of the first survey was 53 years, and 749 (54.0%) were women. Race/ethnicity was white in 76.6% (1063 of 1388) and non-Hispanic black in 8.0% (111 of 1388). Public disclosure of payments was associated with lower trust in one’s own physician regardless of whether respondents knew their physicians had received payments (decrease in Wake Forest measure of trust in one’s own physician of 0.56 point; 95% CI, −0.79 to −0.32 point; P < .001). Open Payments was also associated with lower trust in the medical profession (decrease in Wake Forest measure of trust in the medical profession of 0.35 point; 95% CI, −0.58 to −0.12 point; P = .004). CONCLUSIONS AND RELEVANCE: Nationwide public disclosure of industry payments may be associated with decreased trust in physicians and in the medical profession. More judicious presentation of payments information may counteract unintended negative trust and spillover consequences of public disclosure. American Medical Association 2019-04-12 /pmc/articles/PMC6481437/ /pubmed/30977850 http://dx.doi.org/10.1001/jamanetworkopen.2019.1947 Text en Copyright 2019 Kanter GP et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Kanter, Genevieve P.
Carpenter, Daniel
Lehmann, Lisa S.
Mello, Michelle M.
US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title_full US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title_fullStr US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title_full_unstemmed US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title_short US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
title_sort us nationwide disclosure of industry payments and public trust in physicians
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481437/
https://www.ncbi.nlm.nih.gov/pubmed/30977850
http://dx.doi.org/10.1001/jamanetworkopen.2019.1947
work_keys_str_mv AT kantergenevievep usnationwidedisclosureofindustrypaymentsandpublictrustinphysicians
AT carpenterdaniel usnationwidedisclosureofindustrypaymentsandpublictrustinphysicians
AT lehmannlisas usnationwidedisclosureofindustrypaymentsandpublictrustinphysicians
AT mellomichellem usnationwidedisclosureofindustrypaymentsandpublictrustinphysicians